Alex Philippidis
Will antibody therapies work on patients with severe COVID? Setbacks in new Lilly, Regeneron drugs raise serious doubts
Regeneron Pharmaceuticals and Eli Lilly have [reported clinical study setbacks, which] raised questions about the effectiveness of antibody therapies in ...
160 new coronavirus-fighting drug and vaccine candidates in development
While President Trump continues to promote antimalarial drugs such as hydroxychloroquine sulfate and azithromycin to treat COVID-19 ... the global ...
35 drugs in the race for a coronavirus treatment
As the world scrambles to monitor and contain the COVID-19 outbreak, drug companies are racing to develop or repurpose treatments ...
FDA puts clinical hold on Solid Biosciences’ gene therapy trial for Duchenne muscular dystrophy over toxicity concerns
The FDA has imposed a full clinical hold on Solid Biosciences’ Phase I/II trial for its lead candidate, the Duchenne ...
Genetic cancer screenings based on family history may not go far enough
Simultaneous sequencing of tumor DNA and normal tissue for a broad panel of cancer-related genes may detect more potentially clinically ...
Doctors offer solutions on how to best regulate rising prices of cancer treatments
Fifty years ago, the average monthly cost of a cancer therapy stood at $100 a month ($754.94 in today’s dollars). By 2013, ...
National academies move to design regulations on germline editing
The National Academies of Science (NAS) and National Academies of Medicine (NAM) have their work cut out for them as ...
National Academies gear up to discuss human gene editing implications
The National Academies of Science (NAS) and National Academies of Medicine (NAM) have their work cut out for them as ...
If not anti-science, what’s in the heads and hearts of GMO opponents?
For years, supporters and opponents of genetically-modified organisms (GMOs) have debated questions ranging from the safety of engineered crops, to ...
New gene patent suit sparks talk of trolls
A month after a unanimous U.S. Supreme Court struck down seven Myriad Genetics patents tied to two breast cancer susceptibility genes, the company has touched ...
GMO rider: “Monsanto protection” or “farmer sustainability”?
The following is an excerpt. The biotech industry rejoiced along with biotech seed companies and farmers supportive of genetically modified ...
Genetic Information Nondiscrimination Act under scrutiny
In early February, a team of scientists demonstrated that they could use public databases to link genetic data to its ...
